What Percent of Fertilized Eggs Fail to Develop?

Roughly 40 to 60 percent of fertilized human eggs never result in a live birth, according to analyses that attempt to account for losses at every stage from conception onward.¹ That range surprises most people, because the majority of these losses happen so early that a woman never knows she was pregnant. The familiar statistic that “one in four known pregnancies ends in miscarriage” captures only the visible tail end of a much larger process, one shaped by chromosome errors, uterine gatekeeping, and biological quality controls that operate long before a pregnancy test turns positive.

Why the Numbers Are So Hard to Pin Down

The biggest challenge in quantifying embryo loss is that researchers cannot directly observe what happens between fertilization and implantation in a living person. A fertilized egg spends its first week or so traveling down the fallopian tube and floating in the uterus. Some of those embryos never implant. Others implant briefly but stop developing before they produce enough pregnancy hormone to register on even the most sensitive test. Without a way to detect every fertilization event, scientists have to estimate pre-implantation losses indirectly.

The best available data come from a handful of prospective studies in which women trying to conceive provided daily urine samples so researchers could catch even the faintest, shortest-lived hormonal signals of pregnancy. But even these studies only detect embryos that implant long enough to secrete detectable hormone. Any embryo that fails before implantation is invisible. Older estimates, widely repeated in textbooks, placed total embryo mortality as high as 70 percent or more. A careful re-evaluation of the existing data argued that those headline figures were inflated by including subfertile participants in the study populations, which biased loss rates upward.² The revised estimate for healthy women is that pre-implantation loss falls somewhere in the range of 10 to 40 percent, and total loss from fertilization to birth is around 40 to 60 percent.³

So the honest answer is a range, not a single number. Whether you land closer to the 40 percent end or the 60 percent end depends on how you define a “fertilized egg” (do you count eggs that are fertilized but never divide?), how old the woman is, and whether you include subfertile couples in your calculations. Those differences matter, but even at the low end, the losses are substantial.

Where and When the Losses Happen

It helps to think of embryo attrition as happening in three overlapping windows, each with its own detection challenges.

• Before implantation (days 0 to about 10): The fertilized egg divides, forms a ball of cells, and must hatch from its outer shell and attach to the uterine lining. Some embryos arrest during these early divisions and never reach the uterus. Others arrive but fail to implant. This window accounts for an estimated 10 to 40 percent of fertilized eggs, though the true figure is uncertain because these losses are entirely silent.
• After implantation but before clinical detection (roughly weeks 2 to 5): These are sometimes called “biochemical pregnancies” or subclinical losses. The embryo implants and produces enough hormone to be detectable in a lab assay, but stops developing before it would show up on an ultrasound or even a standard home pregnancy test. One landmark study found that the total rate of pregnancy loss after implantation, including clinically recognized miscarriages, was about 31 percent.⁴ Most of those losses occurred before the woman realized she was pregnant. Research also suggests that the majority of miscarriages happen within the first three weeks after conception, well before many women have taken a pregnancy test.⁵
• Clinical miscarriage (after about week 6): Once a pregnancy is visible on ultrasound, the chance of losing it drops considerably but does not disappear. In one cohort study, about 10 percent of pregnancies confirmed by early ultrasound ended in clinical pregnancy loss.⁶ In lifetime terms, clinical miscarriage is very common: a large study of women who had delivered at least one baby found that 43 percent reported having had one or more first-trimester miscarriages over the course of their reproductive lives.⁷

The steepest drop-off, in other words, happens earliest. By the time a pregnancy makes it to a heartbeat on an ultrasound, it has already survived the riskiest stretch.

Chromosomal Abnormalities Are the Leading Cause

The single biggest reason fertilized eggs fail is that they carry the wrong number of chromosomes. Every time an egg or sperm is made, the parent cell has to split its chromosome pairs apart, and that process is error-prone. When a chromosomally abnormal egg or sperm participates in fertilization, the resulting embryo often cannot develop normally.

Traditional chromosome analysis (karyotyping) of tissue from first-trimester miscarriages finds abnormal results in roughly 40 to 50 percent of cases. One Greek study, for example, found abnormal karyotypes in about 42 percent of miscarriage samples, with extra copies of specific chromosomes being the most common problem.⁸ But newer, more sensitive genomic techniques suggest the true rate is much higher. A study using a high-resolution method called genome haplarithmisis found that roughly a third of miscarriage samples initially classified as chromosomally normal actually harbored detectable genomic imbalances. Combining those findings with conventional karyotype data, the researchers estimated that chromosomal or genomic abnormalities were present in close to 68 percent of first-trimester losses.⁹

Even embryos that look perfectly healthy under a microscope can be carrying hidden errors. Single-cell sequencing of apparently good-quality blastocysts (the five-day-old embryo stage used in IVF) found chromosome mosaicism, meaning a patchwork of normal and abnormal cells, in 82 percent of them.¹⁰ Most of those abnormalities affected a small fraction of the embryo’s cells, and many of those embryos could still develop normally. But the finding underscores just how common chromosome errors are from the very beginning, and how the body has to tolerate a certain level of cellular imperfection to reproduce at all.

The Uterine Lining as Gatekeeper

Not every failed embryo is doomed solely by its own genetics. The uterine lining, or endometrium, plays an active role in deciding which embryos get to implant and which are rejected. This is not a passive surface waiting for any embryo to stick. Research over the past decade has revealed that the endometrium functions as a biosensor, evaluating embryo quality and adjusting its response accordingly.¹¹

The mechanism involves a remarkable dialogue between the embryo and specialized immune cells in the uterus. As the endometrial lining prepares for potential pregnancy each cycle, some of its cells undergo a transformation called decidualization. During this process, certain cells become senescent, producing inflammatory signals. Uterine natural killer cells normally clear these senescent cells, creating a receptive environment. But when researchers exposed these immune cells to signals from embryos that had failed to implant in IVF, the killing of senescent cells was inhibited, suggesting the uterus effectively shut down its receptive state in response to a low-quality embryo.¹² In other words, the uterine lining can distinguish between embryos of different developmental quality and preferentially support the ones with higher potential.

Part of this communication appears to be mediated by tiny packages called extracellular vesicles that the embryo secretes during the peri-implantation period. The molecular cargo inside those vesicles differs depending on embryo quality, and the endometrium responds differently to each type.¹³ This gatekeeping function means that some of what we call “implantation failure” is actually maternal quality control working as intended.

Sperm Quality and the Paternal Contribution

Conversations about embryo loss tend to focus on eggs and the uterus, but the sperm’s DNA matters too. While fertilization itself can proceed normally even with damaged sperm DNA, the consequences show up later. Research has found a clear negative correlation between sperm DNA fragmentation and the rate at which embryos reach the blastocyst stage, with higher fragmentation linked to lower rates of successful development and pregnancy.¹⁴

The timing of the paternal effect is informative. For the first couple of days after fertilization, the embryo runs almost entirely on molecular machinery inherited from the egg. The egg has some capacity to repair damaged sperm DNA during this window. But once the embryo’s own genome switches on, usually around day two or three, unrepaired sperm damage becomes a bigger problem. One study found that embryos from sperm with low DNA damage had consistently higher quality scores and much better implantation rates (65 percent) compared to those from sperm with high DNA damage (about 33 percent).¹⁵

At the cellular level, severe sperm DNA damage can fragment the paternal chromosomes during the very first cell division, leading to chaotic mosaicism where daughter cells end up with wildly different chromosome contents. These embryos typically arrest early in development.¹⁶ This is one reason why fertility clinics are increasingly paying attention to sperm DNA integrity, not just sperm count and motility.

When the Embryo’s Own Genome Fails to Switch On

A fertilized egg initially coasts on proteins and RNA inherited from the mother’s egg cell. Within a few days, the embryo must activate its own genome and begin producing its own molecular toolkit, a transition known as zygotic genome activation. If this handoff fails, the embryo arrests. Studies of embryos that stop developing in the IVF lab suggest that this failure to activate the embryonic genome accounts for a large fraction of early arrests, on the order of 40 percent in some analyses.¹⁷

Detailed single-cell studies of arrested embryos have confirmed that failed genome activation and problems with epigenetic reprogramming, the process of resetting chemical tags on DNA, are strongly associated with developmental arrest.¹⁸ These are not chromosome-number errors in the traditional sense. The embryo may have the right number of chromosomes but still lack the ability to properly read and use its own DNA. Genetic variants in specific genes have been linked to this failure, demonstrating that some cases of recurrent early embryo arrest have a heritable component.¹⁹

Alongside genome activation, the embryo depends heavily on mitochondria inherited from the egg for its energy supply. Mouse studies have shown that when oocyte mitochondria are experimentally damaged, embryos arrest in direct proportion to the severity of the damage.²⁰ Oxidative stress can compound the problem, triggering programmed cell death in early embryos through mitochondrial pathways.²¹ The quality of the egg’s mitochondrial endowment is therefore a fundamental determinant of whether a fertilized egg will develop or stall.

How Maternal Age Shifts the Odds

Age is the single strongest predictor of embryo loss, and the effect is driven almost entirely by changes in egg quality. As women age, the molecular machinery that separates chromosomes during egg formation becomes less reliable. The result is a steep rise in eggs with the wrong number of chromosomes.²² Mitochondrial function in oocytes also tends to decline with age, compounding the problem.

Data from IVF laboratories, where embryo development can be directly observed, put concrete numbers on this effect. A study of nearly 26,000 embryos found that the overall rate of embryo developmental arrest in the lab was about 40 percent. But the rate climbed steadily with age: from a median of 33 percent in women under 35 to 44 percent in women over 42.²³ And those are just the embryos that failed to reach the blastocyst stage in the dish. Additional losses occur at implantation and in early pregnancy, meaning the cumulative odds of a fertilized egg becoming a baby decrease more sharply with age than the lab arrest rate alone suggests.

An interesting nuance from that same study: among the embryos that did reach the blastocyst stage, the rate of chromosomal abnormality was not significantly different across age groups in these good-prognosis patients. That suggests age affects whether an embryo can develop at all, not just whether a surviving embryo is chromosomally normal. In other words, the most severely abnormal embryos in older women may simply arrest before they can be tested.

Environmental Exposures and Oocyte Quality

The egg’s vulnerability to environmental insults adds another dimension to embryo loss. Exposure to certain environmental toxicants can impair oocyte maturation by generating oxidative stress, disrupting mitochondrial function, and interfering with iron metabolism within the cell, all of which reduce the egg’s ability to support embryo development after fertilization.²⁴

One particularly striking example involves PFAS, the “forever chemicals” found in nonstick coatings, waterproof clothing, and drinking water. Mouse studies have shown that even trace-level PFAS contamination in drinking water, at concentrations comparable to what some human populations are exposed to, can reduce oocyte viability and impair blastocyst development within just a few weeks of exposure onset. Increasing PFAS levels were associated with more degenerated oocytes, lower rates of proper egg maturation, and reduced total cell counts in resulting embryos.²⁵ These are animal findings, and direct translation to human fertility is still being worked out. But they suggest that at least some portion of unexplained embryo loss in humans may be traceable to environmental exposures that degrade egg quality before fertilization even takes place.

When Embryo Failure Keeps Repeating

For most couples, the high background rate of embryo loss is invisible. They conceive after a few months of trying and never know about the embryos that didn’t make it. But for some, the losses accumulate in ways that become clinically apparent. Recurrent implantation failure, usually defined in IVF as multiple failed transfers of good-quality embryos, and recurrent miscarriage are at the severe end of the same biological spectrum.

The causes of recurrent failure overlap with the causes of sporadic loss but tend to be more persistent. Immune dysregulation is one recognized contributor, including altered ratios of certain T-cell types and abnormal numbers of natural killer cells and macrophages in the uterine lining.²⁶ Other factors include blood-clotting disorders, anatomical abnormalities of the uterus, imbalances in the uterine microbiome, and, of course, recurring chromosomal errors in embryos.²⁷ In many cases, no single cause is identified, and the problem seems to result from several marginal factors compounding one another.

What IVF Labs Reveal That Nature Hides

IVF has given scientists an unprecedented window into early human development, because embryos are cultured in a dish for the first five or six days. Time-lapse imaging systems, which photograph the embryo every few minutes without disturbing it, have confirmed just how common early arrest is and have identified specific division patterns, like abnormally fast or asymmetric cell divisions, that predict failure.²⁸

That said, it is worth being cautious about extrapolating IVF data to natural conception. IVF embryos are created from eggs matured under hormonal stimulation, fertilized outside the body, and cultured in artificial media. The overall lab arrest rate of around 40 percent is a useful benchmark, but natural conception likely involves its own set of selective pressures, including the uterine biosensoring discussed earlier, that do not exist in a lab dish. Despite extensive research into time-lapse scoring systems and AI-based embryo grading tools, no single measurement has proven to be a reliable, universal predictor of which embryo will produce a baby and which will not.²⁹

How Human Reproduction Compares to Other Mammals

If a 40-to-60 percent failure rate sounds like a design flaw, it helps to know that high embryo loss is not unique to humans. In cattle, fertilization rates are generally above 90 percent, but a large proportion of embryos are lost before day 16 of development. High-producing dairy cows, which are under significant metabolic stress, show even higher and more variable losses, particularly in the first eight days after breeding.³⁰ Early embryo attrition appears to be a conserved feature of mammalian reproduction, not a uniquely human failing.

One way to think about it is that mammals invest heavily in each offspring after birth, so there may be evolutionary pressure to screen embryos aggressively before committing to a full pregnancy. The uterine biosensing mechanisms, the chromosome-counting checkpoint, the mitochondrial quality threshold: all of these act as filters that prevent the body from investing nine months of resources in an embryo that has little chance of becoming a healthy individual. The system is wasteful at the level of individual eggs, but efficient at the level of the organism’s lifetime reproductive success. That framing does not make pregnancy loss any less painful for people experiencing it, but it does place the biology in a broader context. The high attrition rate is not a malfunction. It is how mammalian reproduction was built to work.